Vaccination in Bangladesh
Vaccination in Bangladesh includes all aspects of vaccination in Bangladesh.
A 2020 study reported that the cost of a malaria vaccination program in Bangladesh would be cost effective in terms of increasing the people's disability-adjusted life years.[1]
Bangladesh had its first outbreak of avian influenza in 2007 and the disease continues to be a national problem.[2] Part of the response that scientists recommend is the development of vaccination programs, but this has been difficult.[3]
A 2016 program to provide HPV vaccines to girls created a range of ethical issues for communities.[4] The source of all the problems was that the design of the vaccination program came from foreign people outside the country who had no understanding of local cultural norms.[4] There was an attempt at local consultation, but unexpected problems happened anyway.[4] Problems included lack of public health education for the communities receiving the vaccine, forcefulness and lack of consent in arranging for girls to take the vaccine, a lack of planning to treat adverse side effects of vaccination, and a lack of female leadership and empowerment in running a health program for females.[4]
There are multiple cholera vaccines available in Bangladesh as well as multiple strategies for making them available to people who need them.[5] While there is major government support for vaccination, there is debate and research about how to manage the vaccination program to make it more efficient.[5]
Bangladesh has experienced outbreaks of the Nipah virus and although a vaccine exists, the vaccine option is not well developed and preventing outbreaks without vaccines is a better option in this case.[6]
Bangladesh began a vaccination program for congenital rubella syndrome in 2012 and since then, cases have gone down greatly.[7]
COVID-19 vaccination
Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.[8][9]
EPI (Expanded program on immunization) in Bangladesh
On 7th April 1979, about 5 years after EPI was launched globally by WHO, EPI was formally launched in Bangladesh as a pilot project in eight thanas.[10] In 1985, the People’s Republic of Bangladesh committed to the Global Universal Child Immunization Initiative (UCI), and began a phase-wise process of EPI intensification from 1985-1990.[11]
Bangladesh has made significant progress in the elimination and control of Vaccine-preventable disease (VPDs). The last case of wild Poliovirus was detected in 2006 and maintains Polio free since then. Maternal and neonatal tetanus was eliminated in 2008. Bangladesh also achieved rubella control goal in 2018. Surveillance for AFP and measles is maintained at standard level. Bangladesh has also introduced several new vaccines since last decades. HepB vaccine was introduced in 2003, Hib in 2009, rubella in 2012, PCV and IPV in 2015, MR second dose in 2015 and fIPV in 2017.[12]
| Year | BCG | DPT3/
Penta3 
|
MR1 | Fully
Vaccinated 
|
|---|---|---|---|---|
| 2010 | 98.6 | 88.7 | 84.8 | 79.4 |
| 2011 | 99 | 89.6 | 85.5 | 80.2 |
| 2013 | 95.1 | 92 | 85.5 | 80.7 |
| 2014 | 99.2 | 93 | 86.6 | 81.6 |
| 2015 | 99.3 | 93.6 | 87.4 | 82.5 |
| 2016 | 99.5 | 90.1 | 87.5 | 82.3 |
| 2019 | 99.7 | 93.3 | 88.6 | 83.9 |
References
- ^ Sarker, AR; Sultana, M (2020). "Cost-effective analysis of childhood malaria vaccination in endemic hotspots of Bangladesh". PLOS ONE. 15 (5): e0233902. Bibcode:2020PLoSO..1533902S. doi:10.1371/journal.pone.0233902. PMC 7259743. PMID 32470101.
- ^ Rimi, NA; Hassan, MZ; Chowdhury, S; Rahman, M; Sultana, R; Biswas, PK; Debnath, NC; Islam, SS; Ross, AG (11 September 2019). "A Decade of Avian Influenza in Bangladesh: Where Are We Now?". Tropical Medicine and Infectious Disease. 4 (3): 119. doi:10.3390/tropicalmed4030119. PMC 6789720. PMID 31514405.
- ^ Parvin, R; Nooruzzaman, M; Kabiraj, CK; Begum, JA; Chowdhury, EH; Islam, MR; Harder, T (12 July 2020). "Controlling Avian Influenza Virus in Bangladesh: Challenges and Recommendations". Viruses. 12 (7): 751. doi:10.3390/v12070751. PMC 7412482. PMID 32664683.
- ^ a b c d Salwa, M; Abdullah Al-Munim, T (15 June 2018). "Ethical issues related to human papillomavirus vaccination programs: an example from Bangladesh". BMC Medical Ethics. 19 (Suppl 1): 39. doi:10.1186/s12910-018-0287-0. PMC 6019993. PMID 29945621.
- ^ a b Islam, MT; Chowdhury, F; Qadri, F; Sur, D; Ganguly, NK (29 February 2020). "Trials of the killed oral cholera vaccine (Shanchol) in India and Bangladesh: Lessons learned and way forward". Vaccine. 38: A127–A131. doi:10.1016/j.vaccine.2019.06.082. PMID 31301917. S2CID 196617648.
- ^ Ochani, RK; Batra, S; Shaikh, A; Asad, A (1 June 2019). "Nipah virus – the rising epidemic: a review". Le Infezioni in Medicina. 27 (2): 117–127. PMID 31205033.
- ^ Chan, J; Wu, Y; Wood, J; Muhit, M; Mahmood, MK; Karim, T; Moushumi, F; Jones, CA; Snelling, T; Khandaker, G (2020). "Burden of Congenital Rubella Syndrome (CRS) in Bangladesh: Systematic Review of Existing Literature and Transmission Modelling of Seroprevalence Studies". Infectious Disorders Drug Targets. 20 (3): 284–290. doi:10.2174/1871526518666181004092758. PMID 30289078. S2CID 52921583.
- ^ "Bangladesh starts COVID vaccination drive use". Al Jazeera. 28 January 2021. Retrieved 30 April 2021.
- ^ "Bangladesh starts nationwide COVID vaccination drive use". Anadolu Agency. 7 February 2021. Retrieved 30 April 2021.
- ^ "Expanded Programme on Immunization in Bangladesh: A Success Story". Bangladesh Journals Online.
- ^ "The Immunization Programme in Bangladesh: impressive gains in coverage, but gaps remain" (PDF). Oxford Academic.
- ^ "World Health Organization (WHO)".
See what we do next...
OR
By submitting your email or phone number, you're giving mschf permission to send you email and/or recurring marketing texts. Data rates may apply. Text stop to cancel, help for help.
Success: You're subscribed now !